ORDER Granting Joint Motion to Terminate the Proceeding and Joint Request to Treat Settlement Documents as Business Confidential Information (Paper 80 from joined IPR2020-00324) | Jul 1, 2021 | PAPER | BOARD |
DECISION
Granting Patent Owner's Unopposed Renewed
Motion to Seal Exhibits 2023, 1078, and 1079 | Jun 24, 2021 | PAPER | BOARD |
Trial Instituted Document | Dec 4, 2020 | PAPER | BOARD |
Notice of Accord Filing Date | Aug 21, 2020 | PAPER | BOARD |
Patent Owner's Power of Attorney | Aug 12, 2020 | PAPER | PATENT OWNER |
Patent Owner's Mandatory Notice | Aug 12, 2020 | PAPER | PATENT OWNER |
Ex. 1001 - U.S. Patent No. 8,114,833 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1003 - Prosecution history excerpts for U.S. Patent No. 8,114,833 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Petitioner's Power of Attorney | Jul 22, 2020 | PAPER | PETITIONER |
EXPUNGED | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1004 - International Publication NO. WO 03/002136. | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1005 - International Publication No. WO 2004/004781 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1006 - U.S. Patent No. 6,268,343 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1007 - EP 0 923 950 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1008- Powell et al., Parenteral Peptide Formulations | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1009 - E. Epperson, Mannitol Crystallization in Plastic Containers | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1011 - J. Jacobs, Factors Influencing Drug | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1010 - Griffin et al., Polyhydric Alcohols | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1012 - MODERN PHARMACEUTICS -Part 2 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1012 - MODERN PHARMACEUTICS -Part 3 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1012 - MODERN PHARMACEUTICS -Part 1 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1013 - REMINGTON'S PHARMACEUTICAL SCIENCES (18th ed. 1990) Part 1 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1013 - REMINGTON'S PHARMACEUTICAL SCIENCES (18th ed. 1990) Part 2 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1014 -International Publication No. WO 03/072195 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1017- U.S. Patent No. 8,759,291 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1013 - REMINGTON'S PHARMACEUTICAL SCIENCES (18th ed. 1990) Part 3 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1018 - U.S. Patent Application Publication US 2005/0 48497 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1021 - International Publication No. WO 00/37098 A1 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1022 - Handbook of Pharmaceutical Excipients (3d ed. 2000) | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1019 - International Publication No. WO 95/22560 A1 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1020 - U.S. Patent No. 6,458,924 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1023 - Handbook of Pharmaceutical Excipients (3d ed. 2000) Part 1 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1023 - Handbook of Pharmaceutical Excipients (3d ed. 2000) Part 3 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1023 - Handbook of Pharmaceutical Excipients (3d ed. 2000) Part 4 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1024 -Akers, Formulation Development of Protein Dosage Forms - Part 1 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1024 - Akers, Formulation Development of Protein Dosage Forms - Part 2 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1023 - Handbook of Pharmaceutical Excipients (3d ed. 2000) Part 2 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1023 - Handbook of Pharmaceutical Excipients (3d ed. 2000) Part 4 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1025 - International Patent Publication No. WO 1999/040788 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex, 1026 - DEVELOPMENT OF BIOPHARMACEUTICAL PARENTERAL DOSAGE FORMS (John A. Bontempo ed., 1997) | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1027 -Gaitlin, Formulation and Administration Techniques | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1033 - International Publication No. WO 99/43706 Part 3 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1034 - International Publication No. WO 99/43707 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1028 - A DICTIONARY OF CHEMISTRY (1996) (excerpts) | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1029 - FDA Guidance for Industry - Chemistry Manufacturing and Controls (2003) | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1030 - U.S. Patent No. 5,514,097 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1031 - International Publication No. WO 93/19175 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1032 - International Publication No. WO 99/43705 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1033 - International Publication No. WO 99/43706 Part 1 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1033 - International Publication No. WO 99/43706 Part 2 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1035 - International Publication No. WO 98/08871 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1036 - International Publication No. WO 99/43341 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1037 - International Publication No. WO 99/43708 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1040 -International Publication No. WO 0/11296 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1041 - International Publication No. WO 91/11457 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex, 1042 - International Publication No. WO 98/43658 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1043 - International Publication No. EP 0 708 179 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1044 - International Publication No. EP 0 699 686 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1048 - L. Gerweck et al., Cellular pH Gradient in Tumor Versus Normal Tissue: Potential Exploitation for the Treatment of Cancer | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1049 - Madshus, Regulation of Intracellular pH in Eukaryotic Cells | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1038 - International Publication No. WO 99/43341 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1039 - International Publication No. WO 87/06941 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1045 - International Publication No. WO 01/98331 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1046 - J. Sturis et al., GLP-1 Derivative Liraglutide in Rats with ¿¿-cell Deficiencies | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1047 - Fransson et al., Local Tolerance of Subcutaneous Injections | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1050 - C. Fox et al., Ability to Handle, and Patient Preference for, Insulin Delivery Devices in Visually Impaired Patients with Type 2 Diabetes | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1051 - A.M. Robinson et al., Subcutaneous Versus Intravenous Administration of Heparin in the Treatment of Deep Vein Thrombosis | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1055 - C.M.B. Edwards et al., Peptides as Drugs | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1063 - U.S. Patent No. 4,425,346 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1064 - U.S. Patent No. 6,207,684 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1065 - U.S. Patent No. 6,440,460 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1067 - M.J. Akers, Excipient-Drug Interactions in Parenteral Formulations, | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1052 - D. Schade et al., The Intravenous, Intraperitoneal, and Subcutaneous Routes of Insulin Delivery in Diabetic | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1053 - X.H. Zhou et al., Peptide and Protein Drugs | Jul 22, 2020 | EXHIBIT | PETITIONER |
.Ex. 1054 - Napaporn et al., Assessment of the Myotoxicity of Pharmaceutical Buffers Using an In vitro Muscle Model | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1056 - C. Akiyama et al., Comparison of Behavior in Muscle Fiber Regeneration After Bupivacaine Hydrochloride- and Acid Anhydride-Induced Myonecrosis | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1057 - Alfred Martin, PHYSICAL PHARMACY (4th ed. 1993) | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1058 - S. Borchert et al., Particulate Matter in Parenteral Products | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1059 - X. Chang et al., NMR Studies of the Aggregation of Glucagon-Like Peptide-1: Formation of a Symmetric Helical Dimer | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1060 - M. Stranz et al., A Review of pH and Osmolarity | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1061 - PHARMACEUTICS THE SCIENCE OF DOSAGE FORM DESIGN | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1062 - D. Dubost et al., Characterization of a Solid State Reaction Product from a Lyophilized Formulation of a Cyclic Heptapeptide. A Novel Example of an Excipient-Induced Oxidation | Jul 22, 2020 | EXHIBIT | PETITIONER |
.Ex. 1066 -Bothe et al., Peptide Oligomerization Memory Effects and Their Impact on the Physical Stability of the LP-1 Agonist Liraglutide | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1068 - U.S. PHARMACOPEIA XXII, NATIONAL FORMULARY XVII (1990) -Part 1 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1068 - U.S. PHARMACOPEIA XXII, NATIONAL FORMULARY XVII (1990) -Part 2 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1072 - C. Burke et al., The Adsorption of Proteins to Pharmaceutical Container Surfaces | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1073 - T. Asakura et al., Occurrence of Coring in Insulin Vials and Possibility of Rubber Piece Contamination by Self-Injection | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1074 - M. Roe et al., Dose Accuracy Testing of the Humalog | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1023 - Handbook of Pharmaceutical Excipients (3d ed. 2000) Part 5 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1069 - R. Noel, Statistical Quality Control in the Manufacture of Pharmaceuticals | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1070 - NOTE FOR GUIDANCE SPECIFICATIONS: | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1071 - M. Gnanalingham et al., Accuracy and Reproducibility of Low Dose Insulin Administration Using Pen-Injectors and Syringes | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1076 -WIPO Patentscope PCT Bibliography Data for PCTDK2004000792 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1075 - Parenteral Drug Association, Points to Consider for Cleaning Validation. Technical Report No. 29 Part 1 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1075 - Parenteral Drug Association, Points to Consider for Cleaning Validation. Technical Report No. 29 - Part 2 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1075 - Parenteral Drug Association, Points to Consider for Cleaning Validation. Technical Report No. 29 - Part 3 | Jul 22, 2020 | EXHIBIT | PETITIONER |
Ex. 1002 - EXPERT DECLARATION OF LAIRD FORREST, Ph.D. | Jul 22, 2020 | EXHIBIT | PETITIONER |
IPR Petition '833 | Jul 22, 2020 | PAPER | PETITIONER |
MOTION FOR JOINDER | Jul 22, 2020 | PAPER | PETITIONER |